These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27591681)

  • 1. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
    Fallah A; Weil AG; Wang S; Lewis E; Baca CB; Mathern GW
    Epilepsy Behav; 2016 Oct; 63():79-88. PubMed ID: 27591681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
    de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
    Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
    Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of economic evaluations of treatments for patients with epilepsy.
    Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA
    Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
    Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
    Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex.
    Tong X; Wang X; Qin L; Zhou J; Guan Y; Teng P; Wang J; Yang Y; Li T; Luan G
    Epilepsy Behav; 2022 Jan; 126():108431. PubMed ID: 34883463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
    Aburahma SK; Alzoubi FQ; Hammouri HM; Masri A
    Seizure; 2015 Feb; 25():167-72. PubMed ID: 25468513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
    Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
    Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do certain subpopulations of adults with drug-resistant epilepsy respond better to modified ketogenic diet treatments? Evaluation based on prior resective surgery, type of epilepsy, imaging abnormalities, and vagal nerve stimulation.
    Falco-Walter JJ; Roehl K; Ouyang B; Balabanov A
    Epilepsy Behav; 2019 Apr; 93():119-124. PubMed ID: 30738724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Vagal Nerve Stimulation Treat Drug-Resistant Epilepsy in Patients with Tuberous Sclerosis Complex?
    Grioni D; Landi A
    World Neurosurg; 2019 Jan; 121():251-253. PubMed ID: 30347295
    [No Abstract]   [Full Text] [Related]  

  • 15. Responsive Neurostimulation for the Treatment of Children With Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.
    Karakas C; Houck K; Handoko M; Trandafir C; Coorg R; Haneef Z; Riviello JJ; Weiner HL; Curry D; Ali I
    Pediatr Neurol; 2023 Aug; 145():97-101. PubMed ID: 37302216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis.
    de Kinderen RJ; Lambrechts DA; Wijnen BF; Postulart D; Aldenkamp AP; Majoie MH; Evers SM
    Epilepsia; 2016 Jan; 57(1):41-50. PubMed ID: 26617284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy.
    Wijnen BFM; de Kinderen RJA; Lambrechts DAJE; Postulart D; Aldenkamp AP; Majoie MHJM; Evers SMAA
    Epilepsy Res; 2017 May; 132():91-99. PubMed ID: 28364726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with autism spectrum disorders and drug-resistant epilepsy can benefit from epilepsy surgery.
    Morrison-Levy N; Go C; Ochi A; Otsubo H; Drake J; Rutka J; Weiss SK
    Epilepsy Behav; 2018 Aug; 85():200-204. PubMed ID: 30032808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing epilepsy in tuberous sclerosis complex.
    Thiele EA
    J Child Neurol; 2004 Sep; 19(9):680-6. PubMed ID: 15563014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.